OXYGENATORS MARKET ANALYSIS
Global Oxygenators Market: Key Developments
In August 2020, Terumo Cardiovascular and CytoSorbents temped up to commercialize CytoSorb in Ten U.S. hotspot states under emergency use authorization for COVID-19. The product is useful for providing oxygen exchange in critically ill adults from COVID-19.
In June 2020, NuvOx Pharma received the approval from Health Canada to proceed with the Phase IIa clinical trial of NanO2 in COVID-19 subjects with acute hypoxic respiratory failure (AHRF) where NanO2 can act as a cardioprotectant.
In April 2020, Genrich Membranes developed membrane oxygenator equipment for the treatment of COVID-19 patients. With an urgent requirement of respiratory interventions to treat the critical symptoms of COVID-19, the equipment can be used to treat patients who have been released from Intensive Care Units (ICU).
Need a Custom Report?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now
Credibility and Certifications
9001:2015
27001:2022
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients
U.S.: 
U.K. : 
India : 
